Quercetin inhibits SARS-CoV-2 infection and prevents syncytium formation by cells co-expressing the viral spike protein and human ACE2

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: 1 Online-Ressource.

Language: Englisch

Bibliographic citation: Quercetin inhibits SARS-CoV-2 infection and prevents syncytium formation by cells co-expressing the viral spike protein and human ACE2 ; volume:21 ; number:1 ; day:25 ; month:1 ; year:2024 ; pages:1-13 ; date:12.2024
Virology journal ; 21, Heft 1 (25.1.2024), 1-13, 12.2024

Creator: Roy, Annie V.
Chan, Michael
Banadyga, Logan
He, Shihua
Zhu, Wenjun
Chrétien, Michel
Mbikay, Majambu

Contributor: SpringerLink (Online service)

DOI: 10.1186/s12985-024-02299-w

URN: urn:nbn:de:101:1-2024040512302829875565

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:54 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Roy, Annie V.
Chan, Michael
Banadyga, Logan
He, Shihua
Zhu, Wenjun
Chrétien, Michel
Mbikay, Majambu
SpringerLink (Online service)

Other Objects (12)

Inhalation of ACE2-expressing lung exosomes provides prophylactic protection against SARS-CoV-2

Generation of a lethal mouse model expressing human ACE2 and TMPRSS2 for SARS-CoV-2 infection and pathogenesis

Computational decomposition reveals reshaping of the SARS‐CoV‐2–ACE2 interface among viral variants expressing the N501Y mutation

ACE2: the molecular doorway to SARS-CoV-2

Author Correction: Generation of a lethal mouse model expressing human ACE2 and TMPRSS2 for SARS-CoV-2 infection and pathogenesis

Development of nanoparticles incorporated with quercetin and ACE2-membrane as a novel therapy for COVID-19

Outsmarting SARS-CoV-2 by empowering a decoy ACE2

Intranasal soluble ACE2 improves organ histopathology and survival in k18hACE2 mice infected with SARS-CoV-2

Investigation of Interaction between the Spike Protein of SARS-CoV-2 and ACE2-Expressing Cells Using an In Vitro Cell Capturing System

ACE2-EGFR-MAPK signaling contributes to SARS-CoV-2 infection

Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry

Development of a novel peptide to prevent entry of SARS-CoV-2 into lung and olfactory bulb cells of hACE2 expressing mice

Inhalation of ACE2-expressing lung exosomes provides prophylactic protection against SARS-CoV-2

Generation of a lethal mouse model expressing human ACE2 and TMPRSS2 for SARS-CoV-2 infection and pathogenesis

Computational decomposition reveals reshaping of the SARS‐CoV‐2–ACE2 interface among viral variants expressing the N501Y mutation

ACE2: the molecular doorway to SARS-CoV-2

Author Correction: Generation of a lethal mouse model expressing human ACE2 and TMPRSS2 for SARS-CoV-2 infection and pathogenesis

Development of nanoparticles incorporated with quercetin and ACE2-membrane as a novel therapy for COVID-19

Outsmarting SARS-CoV-2 by empowering a decoy ACE2

Intranasal soluble ACE2 improves organ histopathology and survival in k18hACE2 mice infected with SARS-CoV-2

Investigation of Interaction between the Spike Protein of SARS-CoV-2 and ACE2-Expressing Cells Using an In Vitro Cell Capturing System

ACE2-EGFR-MAPK signaling contributes to SARS-CoV-2 infection

Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry

Development of a novel peptide to prevent entry of SARS-CoV-2 into lung and olfactory bulb cells of hACE2 expressing mice

Inhalation of ACE2-expressing lung exosomes provides prophylactic protection against SARS-CoV-2

Generation of a lethal mouse model expressing human ACE2 and TMPRSS2 for SARS-CoV-2 infection and pathogenesis

Computational decomposition reveals reshaping of the SARS‐CoV‐2–ACE2 interface among viral variants expressing the N501Y mutation

ACE2: the molecular doorway to SARS-CoV-2

Author Correction: Generation of a lethal mouse model expressing human ACE2 and TMPRSS2 for SARS-CoV-2 infection and pathogenesis

Development of nanoparticles incorporated with quercetin and ACE2-membrane as a novel therapy for COVID-19

Outsmarting SARS-CoV-2 by empowering a decoy ACE2

Intranasal soluble ACE2 improves organ histopathology and survival in k18hACE2 mice infected with SARS-CoV-2

Investigation of Interaction between the Spike Protein of SARS-CoV-2 and ACE2-Expressing Cells Using an In Vitro Cell Capturing System

ACE2-EGFR-MAPK signaling contributes to SARS-CoV-2 infection

Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry

Development of a novel peptide to prevent entry of SARS-CoV-2 into lung and olfactory bulb cells of hACE2 expressing mice

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Quercetin inhibits SARS-CoV-2 infection and prevents syncytium formation by cells co-expressing the viral spike protein and human ACE2

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Inhalation of ACE2-expressing lung exosomes provides prophylactic protection against SARS-CoV-2

Generation of a lethal mouse model expressing human ACE2 and TMPRSS2 for SARS-CoV-2 infection and pathogenesis

Computational decomposition reveals reshaping of the SARS‐CoV‐2–ACE2 interface among viral variants expressing the N501Y mutation

ACE2: the molecular doorway to SARS-CoV-2

Author Correction: Generation of a lethal mouse model expressing human ACE2 and TMPRSS2 for SARS-CoV-2 infection and pathogenesis

Development of nanoparticles incorporated with quercetin and ACE2-membrane as a novel therapy for COVID-19

Outsmarting SARS-CoV-2 by empowering a decoy ACE2

Intranasal soluble ACE2 improves organ histopathology and survival in k18hACE2 mice infected with SARS-CoV-2

Investigation of Interaction between the Spike Protein of SARS-CoV-2 and ACE2-Expressing Cells Using an In Vitro Cell Capturing System

ACE2-EGFR-MAPK signaling contributes to SARS-CoV-2 infection

Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry

Development of a novel peptide to prevent entry of SARS-CoV-2 into lung and olfactory bulb cells of hACE2 expressing mice

Inhalation of ACE2-expressing lung exosomes provides prophylactic protection against SARS-CoV-2

Generation of a lethal mouse model expressing human ACE2 and TMPRSS2 for SARS-CoV-2 infection and pathogenesis

Computational decomposition reveals reshaping of the SARS‐CoV‐2–ACE2 interface among viral variants expressing the N501Y mutation

ACE2: the molecular doorway to SARS-CoV-2

Author Correction: Generation of a lethal mouse model expressing human ACE2 and TMPRSS2 for SARS-CoV-2 infection and pathogenesis

Development of nanoparticles incorporated with quercetin and ACE2-membrane as a novel therapy for COVID-19

Outsmarting SARS-CoV-2 by empowering a decoy ACE2

Intranasal soluble ACE2 improves organ histopathology and survival in k18hACE2 mice infected with SARS-CoV-2

Investigation of Interaction between the Spike Protein of SARS-CoV-2 and ACE2-Expressing Cells Using an In Vitro Cell Capturing System

ACE2-EGFR-MAPK signaling contributes to SARS-CoV-2 infection

Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry

Development of a novel peptide to prevent entry of SARS-CoV-2 into lung and olfactory bulb cells of hACE2 expressing mice

Inhalation of ACE2-expressing lung exosomes provides prophylactic protection against SARS-CoV-2

Generation of a lethal mouse model expressing human ACE2 and TMPRSS2 for SARS-CoV-2 infection and pathogenesis

Computational decomposition reveals reshaping of the SARS‐CoV‐2–ACE2 interface among viral variants expressing the N501Y mutation

ACE2: the molecular doorway to SARS-CoV-2

Author Correction: Generation of a lethal mouse model expressing human ACE2 and TMPRSS2 for SARS-CoV-2 infection and pathogenesis

Development of nanoparticles incorporated with quercetin and ACE2-membrane as a novel therapy for COVID-19

Outsmarting SARS-CoV-2 by empowering a decoy ACE2

Intranasal soluble ACE2 improves organ histopathology and survival in k18hACE2 mice infected with SARS-CoV-2

Investigation of Interaction between the Spike Protein of SARS-CoV-2 and ACE2-Expressing Cells Using an In Vitro Cell Capturing System

ACE2-EGFR-MAPK signaling contributes to SARS-CoV-2 infection

Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry

Development of a novel peptide to prevent entry of SARS-CoV-2 into lung and olfactory bulb cells of hACE2 expressing mice

Related objects

Reset password